Kanker Payudara

Global Landmarks to Glow in Teal, Green, and Pink: The 2026 Movement to Fund Metastatic Breast Cancer Research

• Patient Advocacy and Support

Global Landmarks to Glow in Teal, Green, and Pink: The 2026 Movement to Fund Metastatic Breast Cancer Research

Jia Lissa October 16, 2026

NEW YORK, NY — As the sun sets on October 13, 2026, the global skyline will undergo...

Read More Read more about Global Landmarks to Glow in Teal, Green, and Pink: The 2026 Movement to Fund Metastatic Breast Cancer Research

Precision Oncology and the Shift Toward De-escalation: The CompassHER2-pCR Trial Results

• Patient Advocacy and Support

Precision Oncology and the Shift Toward De-escalation: The CompassHER2-pCR Trial Results

Iffa Jayyana October 16, 2026

The landscape of breast cancer treatment is undergoing a fundamental paradigm shift. For decades, the prevailing philosophy...

Read More Read more about Precision Oncology and the Shift Toward De-escalation: The CompassHER2-pCR Trial Results

Global Health Solidarity: WHO Director-General Highlights Jordan’s Role as a Humanitarian Beacon

• Breast Cancer Prevention and Lifestyle

Global Health Solidarity: WHO Director-General Highlights Jordan’s Role as a Humanitarian Beacon

Basiran October 16, 2026

Executive Summary: A Diplomatic Mission for Global Health The Director-General of the World Health Organization (WHO), Dr....

Read More Read more about Global Health Solidarity: WHO Director-General Highlights Jordan’s Role as a Humanitarian Beacon

Fueling the Future: HudsonAlpha Unveils ‘The Primer Lab’ to Supercharge Alabama’s Biotech Ecosystem

• Genomics and Precision Medicine

Fueling the Future: HudsonAlpha Unveils ‘The Primer Lab’ to Supercharge Alabama’s Biotech Ecosystem

Reynand Wu October 16, 2026

HUNTSVILLE, AL – In a strategic move to solidify Alabama’s position as a powerhouse in the life...

Read More Read more about Fueling the Future: HudsonAlpha Unveils ‘The Primer Lab’ to Supercharge Alabama’s Biotech Ecosystem

Olympus Under Regulatory Siege: FDA Warning Letter Triggers Market Turbulence

• Treatment Innovations

Olympus Under Regulatory Siege: FDA Warning Letter Triggers Market Turbulence

Pevita Pearce October 16, 2026

The global medical technology landscape was rattled on October 13, 2026, when Olympus Corporation, a titan in...

Read More Read more about Olympus Under Regulatory Siege: FDA Warning Letter Triggers Market Turbulence

Groundbreaking Research from OU Uncovers How Aggressive Breast Cancer Manipulates Immune System to Fuel Growth, Paving Way for Novel Therapies

• Medical Research and Clinical Trials

Groundbreaking Research from OU Uncovers How Aggressive Breast Cancer Manipulates Immune System to Fuel Growth, Paving Way for Novel Therapies

Azzam Bilal Chamdy October 16, 2026

Norman, OK – In a significant stride against one of the most formidable adversaries in oncology, researchers...

Read More Read more about Groundbreaking Research from OU Uncovers How Aggressive Breast Cancer Manipulates Immune System to Fuel Growth, Paving Way for Novel Therapies

Verastem Oncology Set to Advance KRAS Inhibitor VS-7375 to Phase III Trials Following Promising Data in Pancreatic, Colorectal, and Lung Cancers

• Medical Research and Clinical Trials

Verastem Oncology Set to Advance KRAS Inhibitor VS-7375 to Phase III Trials Following Promising Data in Pancreatic, Colorectal, and Lung Cancers

Nana Muazin October 16, 2026

[City, State] – [Date] – Verastem Oncology is poised to accelerate the development of its novel KRAS...

Read More Read more about Verastem Oncology Set to Advance KRAS Inhibitor VS-7375 to Phase III Trials Following Promising Data in Pancreatic, Colorectal, and Lung Cancers

Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Latest Research Suggests

• Patient Advocacy and Support

Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Latest Research Suggests

Iffa Jayyana October 16, 2026

By Douglas Feil, NBCF Chief Program Officer In recent years, glucagon-like peptide-1 (GLP-1) medications have emerged as...

Read More Read more about Navigating the Intersection of GLP-1 Medications and Breast Cancer: What the Latest Research Suggests

A Global Beacon of Hope: 325 Landmarks to Illuminate for National Metastatic Breast Cancer Awareness Day

• Patient Advocacy and Support

A Global Beacon of Hope: 325 Landmarks to Illuminate for National Metastatic Breast Cancer Awareness Day

Layla Zulfa October 16, 2026

NEW YORK, NY — As the world enters the second week of October, a month traditionally synonymous...

Read More Read more about A Global Beacon of Hope: 325 Landmarks to Illuminate for National Metastatic Breast Cancer Awareness Day

The Dawn of De-escalation: CompassHER2-pCR Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Treatment

• Patient Advocacy and Support

The Dawn of De-escalation: CompassHER2-pCR Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Treatment

Sagoh October 16, 2026

For decades, the standard of care for aggressive breast cancer followed a "more is better" philosophy. In...

Read More Read more about The Dawn of De-escalation: CompassHER2-pCR Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Treatment